|
Market Cap (25-Jun) $19,510,578 (1,113th) |
Close (30-Jun) $0.049 |
Volume (30-Jun) 1,094,468 |
Shortsold (12-Jul) 1 (0.00%) (672nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.45 |
EPS -0.02 |
PXS released this announcement to the ASX on 29 June 2021, 12:28. The announcement is marked as price sensitive, and is 3 page(s) in length and 118.64kb in size.
You can view all announcements from PXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, PXS was 0.000% short sold according to ASIC data. It was ranked the 692nd most shorted stock on the ASX. It is now ranked as the 672nd most shorted stock on the ASX with 0.000% of total shares short sold as of the latest reported data (12 July 2023).
| Other Recent Announcements from PXS | |
|---|---|
| Investor presentation | 24 May 2023, 8:21 |
| PXS Announces Encouraging Results from Phase 1c Scar Study | 23 May 2023, 16:32 |
| Trading Halt | 22 May 2023, 8:56 |
| PXS Announces First Results in Bone Marrow Cancer Trial | 29 June 2021, 12:28 |
| Change of Director's Interest Notice | 29 June 2021, 11:19 |
| Progression of Clinical Trial in Bone Marrow Cancer | 10 June 2021, 14:08 |
| Investor Presentation - 4 June 2021 | 4 June 2021, 10:14 |
You must be logged in to post a reply.
Pharmaxis Ltd 